USP38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.85159953614811E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.46170000945045E-09 |
Normal-vs-Stage2 |
6.10030000000039E-05 |
Normal-vs-Stage3 |
4.26439999999806E-05 |
Normal-vs-Stage4 |
5.775200E-04 |
Stage1-vs-Stage2 |
4.328600E-01 |
Stage1-vs-Stage3 |
5.323200E-01 |
Stage1-vs-Stage4 |
9.645200E-01 |
Stage2-vs-Stage3 |
8.514200E-01 |
Stage2-vs-Stage4 |
6.474600E-01 |
Stage3-vs-Stage4 |
7.657800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.62079971245089E-10 |
Normal-vs-AfricanAmerican |
5.62840000051246E-07 |
Normal-vs-Asian |
1.562950E-03 |
Caucasian-vs-AfricanAmerican |
6.350400E-01 |
Caucasian-vs-Asian |
8.880400E-01 |
AfricanAmerican-vs-Asian |
7.729400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.77828887568421E-12 |
Normal-vs-Female |
2.01009999999391E-05 |
Male-vs-Female |
1.590060E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.44100000399573E-08 |
Normal-vs-Extreme_Weight |
2.62760035951715E-10 |
Normal-vs-Obese |
1.15140000001013E-06 |
Normal-vs-Extreme_Obese |
7.92550000000558E-05 |
Normal_Weight-vs-Extreme_Weight |
7.963200E-01 |
Normal_Weight-vs-Obese |
2.774800E-01 |
Normal_Weight-vs-Extreme_Obese |
9.543800E-01 |
Extreme_Weight-vs-Obese |
9.413600E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.200200E-01 |
Obese-vs-Extreme_Obese |
5.315000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.018400E-04 |
Normal-vs-Age(41-60Yrs) |
2.85850000336652E-08 |
Normal-vs-Age(61-80Yrs) |
4.99650321117429E-11 |
Normal-vs-Age(81-100Yrs) |
5.00830000027541E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.109600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.579400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.503200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.102210E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.988770E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.677000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.80499956595293E-10 |
Normal-VS-Type2 PRCC |
2.40480000357479E-08 |
Normal-VS-KIRP CIMP |
1.460030E-01 |
Normal-VS-Unclassified PRCC |
7.78090000000953E-05 |
Type1 PRCC-VS-Type2 PRCC |
9.984000E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.326630E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.615620E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.750430E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.228200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.598000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.36289876553997E-11 |
Normal-vs-N1 |
1.603130E-03 |
Normal-vs-N2 |
4.559400E-03 |
N0-vs-N1 |
1.177990E-01 |
N0-vs-N2 |
9.291200E-01 |
N1-vs-N2 |
5.525200E-01 |
|
|